BASAGLAR: payments to doctors
Payments that named BASAGLAR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $912K
- Providers
- 22,431
- Transactions
- 71,283
- Average per transaction
- $13
The per-transaction average — $13 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 22,431 providers the average total is $41, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $908,953 | 99.7% |
| Eli Lilly | $3,045 | 0.3% |